Side-alternating Whole Body Vibration in Children With Cerebral Palsy (CP) From 12 Months of Age - Pilot Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cerebral Palsy (CP)
- Sponsor
- University of Cologne
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Change of gross motor function (GMFM-66)
- Status
- Completed
- Last Updated
- 12 years ago
Overview
Brief Summary
Cerebral Palsy (CP) is the most common cause of physical disability in childhood. Up to day the investigators have treated children diagnosed cerebral palsy with side-alternating whole body vibration (System Galileo®) from the age of two years on. Considering verticalisation (standing and walking) at about 12 months of age in a normal developing child the investigators suggest the introduction of verticalisation with whole body vibration to a child with CP at this early age in order to enhance motor development and participation.
In this pilot study the investigators will test the feasibility and the effect on motor development of whole body vibration in children with CP from 12 months of age. The investigators will investigate the effect of whole body vibration on motor performance, independence in all day living situations, quality of life and contractures compared to a control group.
Investigators
Christina Stark
Staff member at the muscle-bone research group
University of Cologne
Eligibility Criteria
Inclusion Criteria
- •Children diagnosed CP
- •≥ 12 months and ≤ 24 months of age (prematures corrected age)
- •GMFCS level II, III, IV
- •Inability to stand and walk
- •Written informed consent of legal guardian
Exclusion Criteria
- •Chronic infectious disease
- •Epilepsy not responding to therapy
- •Additional severe congenital disorder (e.g. congenital heart disorder)
- •Surgery in previous three months
- •Hernia requiring surgery
- •Treatment with Botulinumtoxin
- •Acute Thromboses
- •Implants and tendinitis in body parts to be trained
- •Acute inflammation in the musculoskeletal system
- •Slipped disc
Outcomes
Primary Outcomes
Change of gross motor function (GMFM-66)
Time Frame: Baseline (T0), week 14 (T1, after training) und week 28 (T2, after follow-up)
Secondary Outcomes
- Health-related quality of life (PedsQL)(Baseline (T0), week 14 (T1, after training) und week 28 (T2, after follow-up))
- Participation in activities in daily life (PEDI)(Baseline (T0), week 14 (T1, after training) und week 28 (T2, after follow-up))
- Passive Range of Motion (PROM)(Baseline (T0), week 14 (T1, after training) und week 28 (T2, after follow-up))
- Training compliance(Baseline (T0), week 14 (T1, after training) und week 28 (T2, after follow-up))